NutriBand (NTRB) Research & Development (2021 - 2026)
NutriBand's (NTRB) quarterly Research & Development came in at $188036.0 in Q1 2026, down 61.61% year-on-year from $489856.0 in Q1 2025, and down 58.86% quarter-over-quarter from $457113.0 in Q4 2025.
NutriBand (NTRB) Research & Development (2021 - 2026) Analysis & Trends
NutriBand has disclosed Research & Development across 6 years of filings, most recently posting $188036.0 for Q1 2026.
- Research & Development for Q1 2026 came in at $188036.0, down 61.61% year-over-year; the trailing twelve-month figure through Jan 2026 was $1.9 million (down 39.37% YoY), and the FY2026 annual result was $1.9 million, down 39.37% from the prior year.
- Research & Development came in at $188036.0 for Q1 2026 at NutriBand, down from $457113.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $974535.0 in Q2 2024 to a low of $117814.0 in Q2 2022.
- The 5-year median for Research & Development is $457113.0 (2025), against an average of $482546.9.
- Across the five-year window, Research & Development surged 239.88% in 2023 and sank 61.61% in 2026, its largest moves.
- NutriBand's Research & Development stood at $290718.0 in 2022, then jumped by 89.7% to $551503.0 in 2023, then jumped by 59.7% to $880768.0 in 2024, then sank by 48.1% to $457113.0 in 2025, then tumbled by 58.86% to $188036.0 in 2026.
- The last three Research & Development figures came in at $188036.0 (Q1 2026), $457113.0 (Q4 2025), and $562554.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 1.46 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -2.30 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -58.00 Mn |
| 10 | NutriBand | 41.91 Mn | 37.33 Mn | 88,941.00 | 188,036.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 188,036.00 |
| Oct 31, 2025 | 457,113.00 |
| Jul 31, 2025 | 562,554.00 |
| Apr 30, 2025 | 683,426.00 |
| Jan 31, 2025 | 489,856.00 |
| Oct 31, 2024 | 880,768.00 |
| Jul 31, 2024 | 773,975.00 |
| Apr 30, 2024 | 974,535.00 |
| Jan 31, 2024 | 563,370.00 |
| Oct 31, 2023 | 551,503.00 |
| Jul 31, 2023 | 445,122.00 |
| Apr 30, 2023 | 400,430.00 |
| Jan 31, 2023 | 295,826.00 |
| Oct 31, 2022 | 290,718.00 |
| Jul 31, 2022 | 277,869.00 |
| Apr 30, 2022 | 117,814.00 |
| Jan 31, 2022 | 250,383.00 |
| Oct 31, 2021 | 161,000.00 |